Antieosinophilic Activity of Orazipone
Open Access
- 15 March 2006
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Molecular Pharmacology
- Vol. 69 (6), 1861-1870
- https://doi.org/10.1124/mol.105.021170
Abstract
Orazipone is a novel sulfhydryl-reactive compound that has been previously shown to reduce lung eosinophilia in guinea pigs and rats and to inhibit degranulation in mast cells and cytokine production in monocytes and T-cells. However, the effects of orazipone on granulocyte longevity are unknown. Orazipone and its derivative 3-(4-chloro-3-nitro-benzylidene)-pentane-2,4-dione (OR-2370) reversed interleukin-5-afforded survival of human eosinophils by inducing apoptosis. In contrast, orazipone did not affect granulocyte macrophage-colony-stimulating factor-induced survival of human neutrophils. The effect of orazipone on eosinophil apoptosis is different from that of glucocorticoids in that even high con-centrations of interleukin-5 were not able to overcome the effect of orazipone. Orazipone further enhanced spontaneous apoptosis as well as that induced by CD95 ligation without inducing primary necrosis. OR-2370-induced DNA fragmentation was shown to be dependent on caspases 3 and 6 and c-jun-N-terminal kinase, whereas extracellular regulated kinase, p38 mitogen-activated protein kinase, and phosphatidylinositol 3-kinase as well as caspases 4, 8, and 9 seem not to mediate its actions. Our results suggest that orazipone and its derivative OR-2370 possess strong antieosinophilic activity and thus may have anti-inflammatory efficacy in the treatment of asthma and/or allergic conditions.Keywords
This publication has 31 references indexed in Scilit:
- Pharmacological Regulation of Human Eosinophil ApoptosisCurrent Drug Targets - Inflammation & Allergy, 2005
- Targeting JNK for therapeutic benefit: from junk to gold?Nature Reviews Drug Discovery, 2003
- The Hypereosinophilic Syndrome and the Biology of CancerNew England Journal of Medicine, 2003
- Interleukin-5 inhibits translocation of Bax to the mitochondria, cytochrome c release, and activation of caspases in human eosinophilsBlood, 2001
- Cell-Permeable Peptide Inhibitors of JNKDiabetes, 2001
- Delayed eosinophil apoptosis in asthmaJournal of Allergy and Clinical Immunology, 2000
- Mechanisms of eosinophil-associated inflammationJournal of Allergy and Clinical Immunology, 2000
- Human Eosinophil Isolation and the Measurement of ApoptosisPublished by Springer Science and Business Media LLC ,1999
- Inhibition of interleukin‐5 mediated eosinophil viability by fluticasone 17‐propionate: comparison with other glucocorticoidsClinical and Experimental Allergy, 1998
- Eosinophil apoptosis caused by theophylline, glucocorticoids, and macrolides after stimulation with IL-5Journal of Allergy and Clinical Immunology, 1996